Home

Prescrire Allonger anniversaire non ligand estrogen pathway nf kappa fulvestrant calculer encre Sentiment

Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017  - Reproductive Medicine and Biology - Wiley Online Library
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library

Cancers | Free Full-Text | Nexus between PI3K/AKT and Estrogen Receptor  Signaling in Breast Cancer
Cancers | Free Full-Text | Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer

Estrogen receptor positive breast cancers have patient specific hormone  sensitivities and rely on progesterone receptor | Nature Communications
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor | Nature Communications

A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and  Genomic Signaling - ScienceDirect
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling - ScienceDirect

Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen  Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase |  PLOS ONE
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER

Fulvestrant (R enantiomer) (ICI 182780 (R enantiomer)) | Estrogen  Receptor/ERR | MedChemExpress
Fulvestrant (R enantiomer) (ICI 182780 (R enantiomer)) | Estrogen Receptor/ERR | MedChemExpress

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Frontiers | Microenvironmental Determinants of Breast Cancer Metastasis:  Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like  Growth Factor Signaling
Frontiers | Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling

Targeting estrogen receptor α for degradation with PROTACs: A promising  approach to overcome endocrine resistance - ScienceDirect
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect

Dual-mechanism estrogen receptor inhibitors | PNAS
Dual-mechanism estrogen receptor inhibitors | PNAS

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of  action | British Journal of Cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)

Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer

Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for  Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of  Medicinal Chemistry
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry

Endocrinotherapy resistance of prostate and breast cancer: Importance of  the NF‑κB pathway (Review)
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)

Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... |  Download Scientific Diagram
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram

Frontiers | Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced  Apoptosis in Long-Term Estrogen Deprived Breast Cancer
Frontiers | Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer

The interaction between ER and NFκB in resistance to endocrine therapy |  Breast Cancer Research | Full Text
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text

New insights into acquired endocrine resistance of breast cancer
New insights into acquired endocrine resistance of breast cancer

Cells | Free Full-Text | Endocrine Resistance in Breast Cancer: The Role of  Estrogen Receptor Stability
Cells | Free Full-Text | Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability

エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition
エストロゲン/プロゲストゲン受容体阻害 | Androgen Receptor Inhibition

The role of ERα36 in cell type-specific functions of estrogen and cancer  development - ScienceDirect
The role of ERα36 in cell type-specific functions of estrogen and cancer development - ScienceDirect

The NF-KB pathway and endocrine therapy resistance in breast cancer in:  Endocrine-Related Cancer Volume 26 Issue 6 (2019)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)